Neurocrine Biosciences Ownership | Who Owns Neurocrine Biosciences?
Neurocrine Biosciences Ownership Summary
Neurocrine Biosciences is owned by 91.56% institutional investors, 0.99% insiders, and 7.44% retail investors. Blackrock is the largest institutional shareholder, holding 14.22% of NBIX shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.20% of its assets in Neurocrine Biosciences shares.
NBIX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Neurocrine Biosciences | 91.56% | 0.99% | 7.44% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 34.90% | 10.53% | 54.58% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 14.19M | 14.22% | $1.95B |
| Vanguard group | 10.06M | 10.08% | $1.38B |
| State street | 4.61M | 4.62% | $634.43M |
| Renaissance | 2.47M | 2.47% | $339.79M |
| Jpmorgan chase | 2.36M | 2.37% | $325.28M |
| Bellevue group | 1.90M | 1.90% | $261.39M |
| Geode capital management | 1.82M | 1.82% | $250.11M |
| Price t rowe associates inc /md/ | 1.80M | 1.80% | $247.65M |
| Morgan stanley | 1.54M | 1.55% | $212.68M |
| Dodge & cox | 1.28M | 1.28% | $176.33M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sarissa capital management lp | 410.48K | 9.54% | $56.51M |
| Birchview capital, lp | 42.24K | 5.39% | $5.82M |
| Bellevue group | 1.90M | 4.25% | $261.39M |
| Rock springs capital management lp | 940.00K | 3.90% | $129.41M |
| Braidwell lp | 759.01K | 3.28% | $104.49M |
| Avidity partners management lp | 491.00K | 2.87% | $67.60M |
| Dafna capital management | 71.61K | 2.36% | $9.86M |
| Perceptive advisors | 649.91K | 2.12% | $89.47M |
| Parkman healthcare partners | 115.17K | 2.12% | $15.86M |
| Dsm capital partners | 997.78K | 1.99% | $137.36M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 4.61M | 0.03% | 618.40K |
| Caisse de depot et placement du quebec | 656.12K | 0.22% | 504.44K |
| 1832 asset management | 541.20K | 0.06% | 504.40K |
| Alliancebernstein | 621.87K | 0.03% | 461.64K |
| Norges bank | 449.56K | 0.01% | 449.56K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | - | - | -837.43K |
| Vestal point capital, lp | - | - | -710.00K |
| Morgan stanley | 1.54M | 0.02% | -520.77K |
| Westfield capital management co lp | - | - | -484.78K |
| Janus henderson group | 971.20K | 0.07% | -407.31K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 449.56K | 0.01% | 449.56K | $61.89M |
| Corebridge financial | 128.50K | 0.10% | 128.50K | $17.69M |
| Millennium management | 107.50K | 0.01% | 107.50K | $14.80M |
| C worldwide group | 75.00K | 0.11% | 75.00K | $10.32M |
| Barclays | 60.00K | 0.00% | 60.00K | $8.26M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -4.00 |
| Dt investment partners | -5.00 |
| Geneos wealth management | -7.00 |
| Financial synergies wealth advisors | -9.00 |
| Johnson financial group | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 585 | -3.31% | 92,570,293 | -1.20% | 91 | 1.06% | 297 | -9.17% | 200 | 6.38% |
| Jun 30, 2024 | 596 | -0.83% | 93,638,169 | 0.75% | 93 | 1.08% | 321 | 1.90% | 187 | -10.10% |
| Mar 31, 2024 | 601 | 7.71% | 92,944,071 | 0.73% | 93 | 1.04% | 315 | 5.35% | 208 | 7.22% |
| Dec 31, 2023 | 558 | 6.90% | 92,268,184 | 0.48% | 94 | 1.07% | 299 | 21.54% | 194 | -1.52% |
| Sep 30, 2023 | 522 | 13.23% | 91,829,550 | 0.35% | 93 | 1.07% | 246 | 20.00% | 197 | 7.65% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3.24M | 3.20% | 6.37K |
| Vanguard Total Stock Mkt Idx Inv | 3.19M | 3.15% | -12.62K |
| Vanguard Small Cap Index | 2.53M | 2.50% | 4.95K |
| BB Biotech AG Ord | 1.86M | 1.84% | -22.95K |
| SPDR® S&P Biotech ETF | 1.52M | 1.50% | -46.08K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.50M | 1.48% | -8.54K |
| Vanguard Small Cap Growth Index Inv | 1.39M | 1.37% | -5.59K |
| SPDR® S&P MIDCAP 400 ETF Trust | 794.21K | 0.78% | -11.70K |
| Dodge & Cox Stock I | 700.29K | 0.69% | - |
| iShares Biotechnology ETF | 681.12K | 0.67% | 692.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 17, 2024 | Delaet Ingrid | Chief Regulatory Officer | Sell | $147.28K |
| Nov 29, 2024 | Onyia Jude | Chief Scientific Officer | Sell | $294.37K |
| Oct 03, 2024 | Boyer David W. | Chief Corp. Affairs Officer | Sell | $147.19K |
| Sep 13, 2024 | Boyer David W. | Chief Corp. Affairs Officer | Sell | $421.83K |
| Aug 15, 2024 | RASTETTER WILLIAM H | - | Sell | $2.09M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 18 |
| 2024 Q2 | - | 12 |
| 2024 Q1 | - | 67 |
| 2023 Q4 | - | 16 |
NBIX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools